Investors

Video Testimonial From a Patient Participating in Initial Phase of Our First-In-Human Proof-Of-Concept Trial (PoC1)

Study Evaluating the Safety and Effectiveness of Delivering Transvascular Energy to Ablate Relevant Nerves and Mitigate Pain in Patients with Severe Pancreatic Cancer Pain